Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 26
Phase 32

Trial Status

Completed4
Recruiting2
Terminated3
Other2

Role Distribution

Other Roles11

Activity Timeline

Clinical Trials (11)

NCT07525427Phase 2Recruiting
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Drug Susceptible Pulmonary Tuberculosis
StudydirectorStart date: 2026-04-14
NCT05952076Phase 3Terminated
Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants
PaediatricsUnderweight
StudydirectorStart date: 2023-07-03
NCT05190146Completed
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
Tuberculosis, Pulmonary
StudydirectorStart date: 2021-12-20
NCT04176250Phase 2Completed
Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
Pulmonary Tuberculosis
StudydirectorStart date: 2020-01-16

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen H Gillespie, MB BCh BAO MD DSc

University of St Andrews

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

catherine GEINDRE

Assistance Publique Hopitaux De Marseille

Related
13 trials

Shared therapeutic areas:

Tuberculosis
Similarity Score4%

Sanjay Teotia, M.D

Dr. Sanjay Teotia Clinic, Meerut, U.P , India

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

Vaibhav Gupta, MD

Saanvi MultiSpeciality Clinic, Moradabad, UP, India,

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

Pawan Varshneya, MD

Varshneya Chest Clinic & Eye Care Centre, Aligarh, UP India

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

HIV
Similarity Score4%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Tuberculosis
Similarity Score4%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

HIV
Similarity Score4%

Neeraj Gupta, MD

Dr. Neeraj Gupta, Firozabad ,U.P, India

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

Angela Crook

MRC Clinical Trials Unit

Related
1 trials

Shared therapeutic areas:

Tuberculosis, Pulmonary

Worked with same sponsors:

Global Alliance for TB Drug Development
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT07883226Phase 1StudyDirector

A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11

Healthy Adult Participants
Recruiting
NCT07517445Phase 2StudyDirector

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

Drug Susceptible Pulmonary Tuberculosis
Suspended
NCT07525427Phase 2StudyDirector

Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis

Drug Susceptible Pulmonary Tuberculosis
Recruiting
NCT06062238Phase 3StudyDirector

Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Tuberculosis
Active Not Recruiting
NCT05971602Phase 2StudyDirector

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Pulmonary Tuberculosis
Terminated
NCT05952076Phase 3StudyDirector

Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants

PaediatricsUnderweight
Terminated
NCT05190146StudyDirector

Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden

Tuberculosis, Pulmonary
Completed
NCT05118386Phase 1StudyDirector

Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults

RSV Infection
Completed
NCT04556981Phase 2StudyDirector

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV

Human Immunodeficiency Virus
Completed
NCT04176250Phase 2StudyDirector

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Pulmonary Tuberculosis
Completed
NCT04152161Phase 2StudyDirector

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Tuberculosis
Terminated

All 11 trials loaded